BIT 0.00% 3.3¢ biotron limited

Ann: Letter to Shareholders, page-3

  1. 633 Posts.
    lightbulb Created with Sketch. 101
    Dear Shareholders I am pleased to report that Biotron is in the final stage of three Phase 2 clinical trials for HIV‐1 and COVID‐19. This is a pivotal time for the Company as it completes data collection and analyses of samples and information collected during the trials ahead of the release of headline data in the coming weeks.

    I like the wording "Release of headline data"
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.3¢
Change
0.000(0.00%)
Mkt cap ! $29.77M
Open High Low Value Volume
3.4¢ 3.4¢ 3.3¢ $26.66K 804.7K

Buyers (Bids)

No. Vol. Price($)
1 296338 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 76443 2
View Market Depth
Last trade - 15.00pm 18/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.